241 related articles for article (PubMed ID: 20583992)
1. Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.
Toyohara J; Wu J; Hashimoto K
Curr Top Med Chem; 2010; 10(15):1544-57. PubMed ID: 20583992
[TBL] [Abstract][Full Text] [Related]
2. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
[TBL] [Abstract][Full Text] [Related]
3. An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.
Yin L; Zhao Q; Li L; Zhang SL; Chen XQ; Ma C; Kang L; Liu M; Zhang CL; Yan P; Wang RF
PLoS One; 2013; 8(7):e70188. PubMed ID: 23936161
[TBL] [Abstract][Full Text] [Related]
4. Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Ogawa M; Tsukada H; Hatano K; Ouchi Y; Saji H; Magata Y
Biol Pharm Bull; 2009 Mar; 32(3):337-40. PubMed ID: 19252274
[TBL] [Abstract][Full Text] [Related]
5. The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain.
Horti AG; Villemagne VL
Curr Pharm Des; 2006; 12(30):3877-900. PubMed ID: 17073685
[TBL] [Abstract][Full Text] [Related]
6. Brain imaging of nicotinic receptors in Alzheimer's disease.
Wu J; Ishikawa M; Zhang J; Hashimoto K
Int J Alzheimers Dis; 2010 Dec; 2010():548913. PubMed ID: 21253523
[TBL] [Abstract][Full Text] [Related]
7. Development of radioligands for the imaging of α7 nicotinic acetylcholine receptors with positron emission tomography.
Brust P; Peters D; Deuther-Conrad W
Curr Drug Targets; 2012 May; 13(5):594-601. PubMed ID: 22300025
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.
Horti AG; Ravert HT; Gao Y; Holt DP; Bunnelle WH; Schrimpf MR; Li T; Ji J; Valentine H; Scheffel U; Kuwabara H; Wong DF; Dannals RF
Nucl Med Biol; 2013 Apr; 40(3):395-402. PubMed ID: 23294899
[TBL] [Abstract][Full Text] [Related]
9. Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.
Horti AG
Biochem Pharmacol; 2015 Oct; 97(4):566-575. PubMed ID: 26232729
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease.
Wang S; Fang Y; Wang H; Gao H; Jiang G; Liu J; Xue Q; Qi Y; Cao M; Qiang B; Zhang H
Eur J Med Chem; 2018 Nov; 159():255-266. PubMed ID: 30296684
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches to study the involvement of α7-nAChR in human diseases.
Palma E; Conti L; Roseti C; Limatola C
Curr Drug Targets; 2012 May; 13(5):579-86. PubMed ID: 22300023
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.
Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
PLoS One; 2010 Feb; 5(2):e8961. PubMed ID: 20126539
[TBL] [Abstract][Full Text] [Related]
14. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
[TBL] [Abstract][Full Text] [Related]
16. Neural nAChRs PET imaging probes.
Mo YX; Yin YF; Li YM
Nucl Med Commun; 2014 Feb; 35(2):135-43. PubMed ID: 24240192
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 9-fluorenone derivatives for SPECT imaging of α7-nicotinic acetylcholine receptor.
Gao H; Wang S; Qi Y; He G; Qiang B; Wang S; Zhang H
Bioorg Med Chem Lett; 2019 Dec; 29(23):126724. PubMed ID: 31624040
[TBL] [Abstract][Full Text] [Related]
18. α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia.
Ishikawa M; Hashimoto K
Curr Pharm Des; 2011; 17(2):121-9. PubMed ID: 21355839
[TBL] [Abstract][Full Text] [Related]
19. Selective alpha7 nicotinic acetylcholine receptor ligands.
Mazurov A; Hauser T; Miller CH
Curr Med Chem; 2006; 13(13):1567-84. PubMed ID: 16787204
[TBL] [Abstract][Full Text] [Related]
20. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
